Fingolimod (FTY720) improves the functional recovery and myelin preservation of the optic pathway in focal demyelination model of rat optic chiasm
- 1 November 2019
- journal article
- research article
- Published by Elsevier in Brain Research Bulletin
- Vol. 153, 109-121
Abstract
No abstract availableKeywords
Funding Information
- Babol University of Medical Sciences
This publication has 62 references indexed in Scilit:
- Valproic Acid Attenuates Disease Symptoms and Increases Endogenous Myelin Repair by Recruiting Neural Stem Cells and Oligodendrocyte Progenitors in Experimental Autoimmune EncephalomyelitisNeurodegenerative Diseases, 2013
- Sphingosine 1-Phosphate Receptor 1 as a Useful Target for Treatment of Multiple SclerosisPharmaceuticals, 2012
- Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitisBritish Journal of Pharmacology, 2011
- Fingolimod modulates microglial activation to augment markers of remyelinationJournal of Neuroinflammation, 2011
- Fingolimod provides long‐term protection in rodent models of cerebral ischemiaAnnals of Neurology, 2010
- Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosisNature Reviews Drug Discovery, 2010
- Neurodegeneration in autoimmune CNS inflammationExperimental Neurology, 2010
- Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cellsNature Reviews Drug Discovery, 2009
- Multiple sclerosis: a complicated picture of autoimmunityNature Immunology, 2007
- THE PATHOPHYSIOLOGY OF ACUTE OPTIC NEURITISBrain, 1991